CDTOB
Asset Logo

Castle Minerals Limited

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

N/A
Annual Growth

5 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

0
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Castle Minerals Limited - Option Expiring 07-Jan-2025

📈 Performance

Price History

N/A

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.00

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in CDTOB

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in CDTOB

N/A
CDTOB investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in CDTOB also invest in...

Want more shares? Try these...

Cardiex Limited

CDX

CardieX Ltd. engages in designing, manufacturing, and marketing medical devices used in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The firm develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. The company specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. Its solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and enhance cardiovascular health outcomes. Its suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders all based on the Company’s SphygmoCor vascular biomarker technology. Its products include CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor. CONNEQT Pulse measures both brachial and central blood pressures alongside a suite of vascular biomarkers to provide unparalleled insights into vascular health.

🙌 Performance (5Yr p.a)

-13.79%

📊 Share price

$0.09 AUD

🩺 HEALTH CARE

Find Out More

📊 Share price

$0.02 AUD

Codrus Minerals Ltd. operates as a gold exploration company. The company is headquartered in Perth, Western Australia. The company went IPO on 2021-06-23. The Company’s Karloning REE Project is located about 30 kilometers (km) north of the regional town of Mukinbudin. In addition to its rare earth element (REE) project, it has a portfolio of projects in Western Australia (WA) and Oregon, United States. All of its Australian assets are located in close proximity to existing operating mines and the Bull Run Project in the United States is located in a gold producing area. The company has four projects in WA, comprising about 31 tenements with a total landholding of about 243 square kilometers, which includes the Karloning REE Project in the Wheatbelt, the Silver Swan South and Red Gate Projects are in the Eastern Goldfields, whilst the Middle Creek Project is located in the Eastern Pilbara. In the United States, it holds a 100% legal and beneficial interest for 79 claims and is party to an option agreement, which covers a further 11 claims in Baker County in Eastern Oregon.

📊 Share price

$0.02 AUD

⛏️ MINING

Castle Minerals Ltd. engages in the exploration of mineral properties in Ghana, West Africa. The company is headquartered in Perth, Western Australia. The company went IPO on 2006-05-02. The firm has interests in several projects in Ghana and Western Australia that are prospective for battery metals (graphite and lithium), base metals (zinc, lead, and copper) and gold. In Ghana, West Africa, the emerging flagship Kambale Graphite Project is owned by its Ghanaian subsidiary, Kambale Graphite Limited. Its Ghanaian subsidiary, Carlie Mining Ltd, holds a 2,686 square kilometers tenure position in the same Upper West region. Its projects in Western Australia include Earaheedy Basin project, Beasley Creek project, Polelle project, Wilgee Springs project, and Woodcutters project. The Earaheedy Basin project comprises the Withnell and Terra Rossa sub-projects. The Beasley Creek project is prospective for gold and lithium and lies on the northern flanks of the Rocklea Dome in the southern Pilbara. The Polelle project, about seven kilometers southeast of the operating Bluebird gold mine near Meekatharra.

🙌 Performance (5Yr p.a)

-15.56%

📊 Share price

$0.00 AUD

⛏️ MINING

Compare
Add to watchlist